The Cell Permeant Phosphopetpide mimetic of VASP Alleviates Motor Function Deficits After Experimental Subarachnoid Hemorrhage

Keyphrases

• Actin-binding Proteins 20%
• Cerebral Vasculature 20%
• Cerebral Vasospasm 20%
• Cisterna Magna Injection 20%
• Clinical Efficacy 20%
• Delayed Vasospasm 20%
• Experimental Subarachnoid Hemorrhage 100%
• Hemodynamic Optimization 20%
• High Dose 20%
• Intracranial Aneurysm 20%
• Intravenous Administration 40%
• Motor Deficits 100%
• Neuroischemic 20%
• Neurologic Death 20%
• Neurologic Deficit 60%
• Nimodipine 20%
• Nitric Oxide 20%
• Permeant 100%
• Phosphopeptides 20%
• Protein Kinase G 40%
• Rat Model 20%
• Rotarod Test 20%
• Signaling Elements 20%
• Subarachnoid Hemorrhage 100%
• Systemic Hypotension 20%
• Therapeutic Potential 20%
• Therapeutic Window 20%
• Vascular Smooth muscle Cells 20%
• Vasorelaxation 20%

Medicine and Dentistry

• Actin 20%
• Brain Vasospasm 20%
• Cisterna Magna 20%
• Cyclic GMP Dependent Protein Kinase 40%
• Downregulation 20%
• Drug Megadose 20%
• Experimental Subarachnoid Hemorrhage 100%
• Hemodynamic 20%
• Hypotension 20%
• Intracranial Aneurysm 20%
• Low Drug Dose 20%
• Motor Performance 100%
• Nimodipine 20%
• Nitric Oxide 20%
• Phosphopeptide 20%
• Subarachnoid Hemorrhage 100%
• Therapeutic Window 20%
• Vascular Smooth Muscle Cell 20%
• Vascularity 20%
• Vasodilatation 20%
• Vasodilator Stimulated Phosphoprotein 100%
• Vasospasm 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Actin 20%
• Brain Vasospasm 20%
• Cyclic GMP Dependent Protein Kinase 40%
• Experimental Subarachnoid Hemorrhage 100%
• Hypotension 20%
• Intracranial Aneurysm 20%
• Nimodipine 20%
• Nitric Oxide 20%
• Phosphopeptide 20%
• Rat Model 20%
• Subarachnoid Hemorrhage 100%
• Therapeutic Window 20%
• Vasodilator Stimulated Phosphoprotein 100%
• Vasospasm 20%